CMS Urged to Consider Specialists When Implementing MIPS Value Pathways

ASCP recently cosigned a letter developed by the American Medical Association (AMA) to address concerns with CMS’ implementation of the MIPS Value Pathways (MVPs) – a new construct designed to reduce burden and focus reporting on patient outcomes and care episodes. While we agree that the MVPs are a step in the right direction in terms of streamlining program requirements, ASCP is concerned with how non-patient facing specialties, like pathology, will fit into the new schema. Specifically, the Promoting Interoperability category is the proposed cornerstone of the MVPs and pathologists are exempt from this category. Additionally, there is little information on how Qualified Clinical Data Registry data will be integrated into the program.

Other articles in the May 2020 ePolicy News:

• New Law Includes Funding for COVID-19 Testing, ASCP Recommendations for Testing Strategy
• ASCP Urges Creation of National COVID-19 Testing Task Force
• AMA Endorses ASCP’s Call for a National Testing Strategy
• Governors, State Health Directors Hear from ASCP BOC about COVID-19 Response
• ASCP, FDA Share Similar Concerns on Antigen Testing
• Hazard Pay, Mental Health Benefits Sought for Pathologists, Laboratory Professionals
• ASCP Interviewed about Job Satisfaction, Well-Being of Pathologists
•  Updated Risk-Based Guidelines Now Published for Management of Abnormal Results in Cervical Cancer Screening and Colposcopy

To read more articles from ePolicy News click here.

For more information regarding ASCP's advocacy initiatives and policy positions, please contact ASCP's Center for Public Policy at (202) 408-1110.

ASCP ePolicy News is supported by an unrestricted grant from Hologic.